Inagene Diagnostics Inc. is proud to attend the Canadian Pain Society webinar co-presented by our Chief Science Advisor, Katherine Siminovitch on November 10th
Nancy White, CEO of Inagene Diagnostics participated in a Panel Discussion at the 20th Annual Healthcare Summit (October 26-27, 2020), which focused on how COVID-19 is changing the private and public healthcare sector, both in terms of impacts as well as opportunities.
Inagene Diagnostics Inc. had the pleasure of attending and proudly sponsoring the Pain Society of Alberta’s Virtual Pain Conference – a history making event as, with over 4200 Registrants, it was the largest pain conference in Canada’s history!
Inagene Diagnostics Inc is excited to announce a new partnership with dnaPower Inc., a fellow Canadian company, specializing in applying the power of genetics to help individuals make better, data driven decisions, about their health!
By: Karen Adams, Healthcare Advisor, Optimize Care Inc. COVID 19 has changed all of our lives in many respects, including creating a heightened focus on the value of maintaining the health, safety, and wellness of our society. Now, more than ever, we are conscious of any factors that may put our health at heightened risk, and increased focus is being placed on designing our healthcare system to be easy and safe for all to navigate.
YummyMummy Club guest author reflects on her families difficult journey with opioid dependence, and shares her hope that pharmacogenetics can help more people avoid drug dependency and painful medication side effects.
